Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million on February 20, 2024. The transaction is expected to complete by the end of February 2024 and is subject fulfilment of certain conditions.